CzÄ™Å›Ä‡ 1 A - Wykaz produktÃ³w leczniczych dopuszczonych do

More documents

Recommendations

Info

Lp. Nazwa produktu leczniczego Skład Postać farmaceutyczna Dawka Wielkość opakowania Kat. dost. Podmiot odpowiedzialny 1941 Czopki glicerynowe GEMI Glyceroli suppositoria czopki doodbytnicze 2 g 10 szt. 2 g OTC Grzegorz Nowakowski Przedsiębiorstwo Produkcji Farmaceutycznej "GEMI" 1942 Czopki przeciw hemoroidom 1943 D - Szczepionka błonicza adsorbowana Suppositoria antihaemorrhoidales Vaccinum diphtheriae adsorbatum 1944 D.T.COQ Vaccinum diphtheriae, tetani et pertussis adsorbatum czopki doodbytnicze 10 szt. OTC Przedsiębiorstwo Produkcji Farmaceutycznej HASCO- LEK S.A. zawiesina do wstrzykiwań zawiesina do wstrzykiwań domięśniowych 1945 Dacarbazin Pliva Dacarbazinum proszek do sporządzania roztworu do wstrzykiwań i infuzji 1946 Dacarbazin Pliva Dacarbazinum proszek do sporządzania roztworu do wstrzykiwań i infuzji 1947 Dafalgan codeine Paracetamolum + Codeini phosphas tabletki powlekane 500 mg + 30 mg 20 dawek 0,5 ml (1 dawka) 1 fiol. 10 ml Rp Instytut Biotechnologii Surowic i Szczepionek BIOMED S.A. Numer pozwolenia Wytwórca IL-3722/LN Grzegorz Nowakowski Przedsiębiorstwo Produkcji Farmaceutycznej "GEMI" IL-4309/LN Przedsiębiorstwo Produkcji Farmaceutycznej HASCO- LEK S.A. 39 Instytut Biotechnologii Surowic i Szczepionek BIOMED S.A. Kraj wytwórcy 1 strzyk. 0,5 ml Rp Sanofi Pasteur S.A. 9116 Sanofi Pasteur S.A. F 100 mg 1 fiol. proszku 10 fiol. proszku 200 mg 1 fiol. proszku 10 fiol. proszku 1948 Dafnegin Ciclopiroxum olaminum krem dopochwowy 10 mg/g 1 tuba 78 g + 14 aplikatorów 1949 Daivobet Calcitoninum humanum + maść (50 mcg + 1 tuba 3 g Betamethasonum 0,5 mcg)/g 1 tuba 15 g 1 tuba 30 g 1 tuba 60 g 1 tuba 100 g 1 tuba 120 g 1950 Daivonex Calcipotriolum krem 50 mcg/g 1 tuba 30 g 1 tuba 100 g Lz Lz Lz Lz 16 tabl. Rp Bristol-Meyers Squibb Polska Sp. z o.o. Pliva-Lachema a.s. 4669 Pliva-Lachema a.s. CZ Pliva-Lachema a.s. 4670 Pliva-Lachema a.s. CZ 6797 Bristol-Myers Squibb F Rp Polichem S.A. 1541 Doppel Farmaceutici S.r.l. I Rp Rp Rp Rp Rp Rp Rp Rp Leo Pharmaceutical Products Ltd. A/S Leo Pharmaceutical Products Ltd. A/S 1951 Daivonex Calcipotriolum maść 50 mcg/g 1 tuba 30 g Rp Leo Pharmaceutical Products Ltd. A/S 1952 Daivonex Calcipotriolum płyn na skórę 50 mcg/ml 1 butelka 30 ml Rp Leo Pharmaceutical 1 butelka 60 ml Rp Products Ltd. A/S 1953 Daktarin Miconazoli nitras krem 20 mg/g 1 op. 15 g OTC McNeil Products Ltd. C/O 1 op. 30 g OTC Johnson & Johnson Ltd. 1954 Daktarin Miconazoli nitras puder leczniczy 20 mg/g 1 op. 20 g OTC McNeil Products Ltd. C/O Johnson & Johnson Ltd. Strona 186 z 854 9797 Leo Pharmaceutical Products Ltd. A/S PL PL PL DK 9481 Leo Laboratoires Ltd. IRL 6996 Leo Laboratoires Ltd. IRL 9482 Leo Pharmaceutical Products Ltd. A/S 2806 Janssen Pharmaceutica N.V. 7798 Lusomedicamenta - Sociedade Tecnica Farmaceutica S.A. DK B P
Lp. Nazwa produktu leczniczego Skład Postać farmaceutyczna 1955 Daktarin Miconazoli nitras puder leczniczy do rozpylania na skórę Dawka Wielkość opakowania Kat. dost. Podmiot odpowiedzialny 20 mg/g 1 poj. 100 g OTC McNeil Products Ltd. C/O Johnson & Johnson Ltd. Numer pozwolenia Wytwórca Kraj wytwórcy 8503 Pharmasol Ltd. GB 1956 Daktarin-oral Miconazolum żel do stosowania w 20 mg/g 1 op. 40 g Rp Janssen-Cilag 6771 Janssen Pharmaceutica jamie ustnej International N.V. N.V. 1957 Dalacin Clindamycini phosphas krem 20 mg/g (2%) 1 op. 40 g Rp Pfizer Ltd. 7131 Pfizer Manufacturing Belgium N.V. 1958 Dalacin C Clindamycinum granulat do 75 mg/5 ml 1 op. 80 ml Rp Pfizer Europe MA EEIG 3450 Pfizer Manufacturing sporządzania syropu (32 g granulatu) Belgium N.V. 1959 Dalacin C Clindamycinum kapsułki 75 mg 16 kaps. Rp Pfizer Manufacturing 711 Pfizer PGM F 20 kaps. Rp Belgium N.V. 1960 Dalacin C Clindamycinum kapsułki 150 mg 16 kaps. Rp Pfizer Manufacturing 712 Pfizer PGM F 20 kaps. Rp Belgium N.V. 100 kaps. Rp 1961 Dalacin C Clindamycinum kapsułki 300 mg 16 kaps. Rp Pfizer Manufacturing 3064 Pfizer PGM F 20 kaps. Rp Belgium N.V. 1962 Dalacin C Clindamycinum roztwór do 150 mg/ml 1 amp. 2 ml Rp Pfizer Europe MA EEIG 713 Pfizer Manufacturing B wstrzykiwań i infuzji 1 amp. 4 ml Rp Belgium N.V. 1 amp. 6 ml Rp 1963 Dalacin T Clindamycinum emulsja na skórę 10 mg/ml 1 op. 30 ml Rp Pharmacia Ltd. 2910 Pfizer Manufacturing B 1 op. 60 ml Rp Belgium N.V. 1964 Dalacin T Clindamycinum płyn na skórę 10 mg/ml 1 op. 30 ml Rp Pfizer Manufacturing 1464 Pfizer Manufacturing B Belgium N.V. Belgium N.V. 1965 Dalacin T Clindamycinum żel 10 mg/g 1 op. 30 g Rp Pfizer Ltd. 7491 Pfizer Manufacturing Belgium N.V. B 1966 Dalfaz Alfuzosini hydrochloridum tabletki powlekane 2,5 mg 30 tabl. Rp Sanofi-Aventis France 6812 Sanofi Winthrop Industrie F 1967 Dalfaz SR 5 Alfuzosini hydrochloridum tabletki powlekane o przedłużonym uwalnianiu 1968 Dalfaz Uno Alfuzosini hydrochloridum tabletki o przedłużonym uwalnianiu 1969 Damiana Preparat homeopatyczny granulki granulki w pojemniku jednodawkowym krople doustne, roztwór 5 mg 20 tabl. 60 tabl. 10 mg 30 tabl. w blistrach 30 tabl. w pojemniku 2CH-200CH; 6K-CMK 2CH-200CH; 6K-CMK 2CH-200CH; 6K-CMK 1 poj. 4 g 1 poj. 1 g 1 butelka 30 ml + kroplomierz 1 butelka 60 ml + strzyk. 1 butelka 125 ml + strzyk. 1 butelka 250 ml + strzyk. Strona 187 z 854 Rp Rp Rp Rp OTC (2CH- 15CH) Rp (16CH- 200CH ; 6K- CMK) Sanofi-Aventis France 8127 Sanofi-Winthrop Industrie F Sanofi-Aventis France 8378 Sanofi-Synthelabo Ltd. Sanofi-Winthrop Industrie Boiron S.A. 19195 Boiron S.A. F B B B GB F
Page 1 and 2:
Lp. Nazwa produktu leczniczego Skł
Page 3 and 4:
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Lp. Nazwa produktu leczniczego 358
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136: Lp. Nazwa produktu leczniczego Skł
Page 157 and 158: Lp. Nazwa produktu leczniczego 1629
Page 185: Lp. Nazwa produktu leczniczego Skł
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Lp. Nazwa produktu leczniczego Sk?a
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
Page 357 and 358:
Page 359 and 360:
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
Page 375 and 376:
Page 377 and 378:
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
Page 423 and 424:
Page 425 and 426:
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Page 435 and 436:
Page 437 and 438:
Page 439 and 440:
Page 441 and 442:
Page 443 and 444:
Page 445 and 446:
Page 447 and 448:
Page 449 and 450:
Page 451 and 452:
Page 453 and 454:
Page 455 and 456:
Page 457 and 458:
Page 459 and 460:
Page 461 and 462:
Page 463 and 464:
Page 465 and 466:
Page 467 and 468:
Page 469 and 470:
Page 471 and 472:
Page 473 and 474:
Page 475 and 476:
Page 477 and 478:
Page 479 and 480:
Page 481 and 482:
Page 483 and 484:
Page 485 and 486:
Page 487 and 488:
Page 489 and 490:
Page 491 and 492:
Page 493 and 494:
Lp. 5400 Natecal D 3 Nazwa produktu
Page 495 and 496:
Page 497 and 498:
Page 499 and 500:
Page 501 and 502:
Page 503 and 504:
Page 505 and 506:
Page 507 and 508:
Page 509 and 510:
Page 511 and 512:
Page 513 and 514:
Page 515 and 516:
Page 517 and 518:
Page 519 and 520:
Page 521 and 522:
Page 523 and 524:
Page 525 and 526:
Page 527 and 528:
Page 529 and 530:
Page 531 and 532:
Page 533 and 534:
Page 535 and 536:
Page 537 and 538:
Page 539 and 540:
Page 541 and 542:
Page 543 and 544:
Page 545 and 546:
Page 547 and 548:
Page 549 and 550:
Page 551 and 552:
Page 553 and 554:
Page 555 and 556:
Page 557 and 558:
Page 559 and 560:
Page 561 and 562:
Page 563 and 564:
Page 565 and 566:
Page 567 and 568:
Page 569 and 570:
Page 571 and 572:
Page 573 and 574:
Page 575 and 576:
Page 577 and 578:
Page 579 and 580:
Page 581 and 582:
Page 583 and 584:
Page 585 and 586:
Page 587 and 588:
Page 589 and 590:
Page 591 and 592:
Page 593 and 594:
Page 595 and 596:
Page 597 and 598:
Page 599 and 600:
Page 601 and 602:
Page 603 and 604:
Page 605 and 606:
Page 607 and 608:
Page 609 and 610:
Page 611 and 612:
Page 613 and 614:
Page 615 and 616:
Page 617 and 618:
Page 619 and 620:
Page 621 and 622:
Page 623 and 624:
Page 625 and 626:
Page 627 and 628:
Page 629 and 630:
Page 631 and 632:
Page 633 and 634:
Page 635 and 636:
Page 637 and 638:
Page 639 and 640:
Page 641 and 642:
Page 643 and 644:
Page 645 and 646:
Page 647 and 648:
Page 649 and 650:
Page 651 and 652:
Page 653 and 654:
Page 655 and 656:
Page 657 and 658:
Page 659 and 660:
Page 661 and 662:
Page 663 and 664:
Page 665 and 666:
Page 667 and 668:
Page 669 and 670:
Page 671 and 672:
Page 673 and 674:
Page 675 and 676:
Page 677 and 678:
Page 679 and 680:
Page 681 and 682:
Page 683 and 684:
Page 685 and 686:
Page 687 and 688:
Page 689 and 690:
Page 691 and 692:
Page 693 and 694:
Page 695 and 696:
Page 697 and 698:
Page 699 and 700:
Page 701 and 702:
Page 703 and 704:
Page 705 and 706:
Page 707 and 708:
Page 709 and 710:
Page 711 and 712:
Page 713 and 714:
Page 715 and 716:
Page 717 and 718:
Page 719 and 720:
Page 721 and 722:
Page 723 and 724:
Page 725 and 726:
Page 727 and 728:
Page 729 and 730:
Page 731 and 732:
Page 733 and 734:
Page 735 and 736:
Page 737 and 738:
Page 739 and 740:
Page 741 and 742:
Page 743 and 744:
Page 745 and 746:
Page 747 and 748:
Page 749 and 750:
Page 751 and 752:
Page 753 and 754:
Page 755 and 756:
Page 757 and 758:
Page 759 and 760:
Page 761 and 762:
Page 763 and 764:
Page 765 and 766:
Page 767 and 768:
Page 769 and 770:
Page 771 and 772:
Page 773 and 774:
Page 775 and 776:
Page 777 and 778:
Page 779 and 780:
Page 781 and 782:
Page 783 and 784:
Page 785 and 786:
Page 787 and 788:
Page 789 and 790:
Page 791 and 792:
Page 793 and 794:
Page 795 and 796:
Page 797 and 798:
Page 799 and 800:
Page 801 and 802:
Page 803 and 804:
Page 805 and 806:
Page 807 and 808:
Page 809 and 810:
Page 811 and 812:
Page 813 and 814:
Page 815 and 816:
Page 817 and 818:
Page 819 and 820:
Page 821 and 822:
Page 823 and 824:
Page 825 and 826:
Page 827 and 828:
Page 829 and 830:
Page 831 and 832:
Page 833 and 834:
Page 835 and 836:
Page 837 and 838:
Page 839 and 840:
Page 841 and 842:
Page 843 and 844:
Page 845 and 846:
Page 847 and 848:
Page 849 and 850:
Page 851 and 852:
Page 853 and 854:
show all

CzÄ™Å›Ä‡ 1 A - Wykaz produktÃ³w leczniczych dopuszczonych do

Create successful ePaper yourself

Delete template?

Save as template?